Advertisement

Child's Nervous System

, Volume 28, Issue 7, pp 1017–1024 | Cite as

Diagnostic utility and correlation of tumor markers in the serum and cerebrospinal fluid of children with intracranial germ cell tumors

  • Ibrahim Qaddoumi
  • Miheer Sane
  • Shaoyu Li
  • Mehmet Kocak
  • Atmaram Pai-Panandiker
  • Julie Harreld
  • Paul Klimo
  • Karen Wright
  • Alberto Broniscer
  • Amar Gajjar
Original Paper

Abstract

Purpose

In order to predict whether tumor markers assist in the histopathologic diagnosis of germ cell tumors (GCTs), we analyzed the correlation of beta human chorionic gonadotropin (βhCG) and alpha-fetoprotein (AFP) in serum and cerebrospinal fluid (CSF) samples at baseline and subsequent follow-up examinations.

Method

A retrospective study of patients diagnosed with intracranial GCTs between July 1985 and February 2011 at our institution was conducted to review clinical, surgical, radiological, laboratory, and histopathologic data.

Results

Of the 67 patients eligible for the study, 42 had germinomas and 25 non-germinomatous GCTs. At baseline, serum and CSF AFP agreed in 97.9 % of patients (Cohen’s Kappa 0.93). Baseline βhCG samples agreed in only 72.5 % of patients (Cohen’s Kappa 0.46). In most cases, values were higher in serum for AFP and in CSF for βhCG. ROC curves estimated from logistic regression model indicated that CSF and serum samples had almost equal diagnostic utility, and the DeLong test showed that the difference in area under curves was not statistically significant. During follow-up (185 paired CSF and serum values from 43 patients), 90.3 % of AFP values correlated between CSF and serum (Cohen’s Kappa 0.22, showing fair agreement). For βhCG, 96.2 % of values agreed in serum and CSF (Cohen’s Kappa 0.61).

Conclusions

In some patients, intracranial GCTs can be diagnosed based solely upon positive serum AFP values. In addition, marker values from serum only may be sufficient to predict tumor relapse at interval follow-up examinations.

Keywords

Germ cell tumors Tumor markers Beta human chorionic gonadotropin Alpha-fetoprotein Correlation of markers Diagnostic utility 

Notes

Acknowledgments

This work was supported in part by Cancer Center Support Grant CA21765 from the National Cancer Institute, The Noyes Brain Tumor Foundation, Musicians Against Childhood Cancer, and the American Lebanese Syrian Associated Charities. The authors would like to acknowledge Vani Shanker for the scientific editing of the manuscript and Julie Groff for support of the artwork.

References

  1. 1.
    Adler MD, Comi AE, Walker AR (2001) Acute hemorrhagic complication of diagnostic lumbar puncture. Pediatr Emerg Care 17:184–188PubMedCrossRefGoogle Scholar
  2. 2.
    Allen JC, Donahue B, Mathew N et al (2010) Can serum and/or lumbar CSF BHCG be used to diagnose A CNS germinoma. Neuro-Oncology 12:i29Google Scholar
  3. 3.
    Bernstein L, Smith MA, Liu L et al (1994) Germ cell, trophoblastic and other gonadal neoplasm ICCC X. SEER Pediatric Monograph 125–137Google Scholar
  4. 4.
    Blohm ME, Vesterling-Horner D, Calaminus G, Gobel U (1998) Alpha-fetoprotein (AFP) reference values in infants up to 2 years of age. Pediatr Hematol Oncol 15:135–142PubMedCrossRefGoogle Scholar
  5. 5.
    Coakley J, Kellie SJ, Munas A, Cooke-Yarborough C (2005) Interpretation of alpha-fetoprotein concentrations in cerebrospinal fluid in infants. Ann Clin Biochem 42:24–29PubMedCrossRefGoogle Scholar
  6. 6.
    Echevarria ME, Fangusaro J, Goldman S (2008) Pediatric central nervous system germ cell tumors: a review. Oncologist 13:690–699PubMedCrossRefGoogle Scholar
  7. 7.
    Fujimaki T (2009) Central nervous system germ cell tumors: classification, clinical features, and treatment with a historical review. J Child Neurol 24:1439–1445PubMedCrossRefGoogle Scholar
  8. 8.
    Fujimaki T, Mishima K, Asai A, Tabuchi K, Kobayashi M, Suzuki I, Kirino T (2000) Levels of beta-human chorionic gonadotropin in cerebrospinal fluid of patients with malignant germ cell tumor can be used to detect early recurrence and monitor the response to treatment. Jpn J Clin Oncol 30:291–294PubMedCrossRefGoogle Scholar
  9. 9.
    Gilligan TD, Seidenfeld J, Basch EM et al (2010) American society of clinical oncology practice guidelines on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol 28:3388–3404PubMedCrossRefGoogle Scholar
  10. 10.
    Gregory JJ, Finlay JL (1999) Alpha-fetoprotein and beta-human chorionic gonadotropin their clinical significance as tumour markers. Drugs 57:463–467PubMedCrossRefGoogle Scholar
  11. 11.
    Honegger J, Mann K, Thierauf P, Zrinzo A, Fahlbusch R (1995) Human chorionic gonadotropin immunoactivity in cystic intracranial tumours. Clin Endocrinol 42:235–241CrossRefGoogle Scholar
  12. 12.
    Kawaguchi T, Kumabe T, Kanamori M et al (2011) Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with a better response among highly malignant intracranial non-germinomatous germ cell tumors. J Neurooncol 104:779–787PubMedCrossRefGoogle Scholar
  13. 13.
    Kim A, Ji L, Balmaceda C et al (2008) The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors. Pediatr Blood Cancer 51:768–773PubMedCrossRefGoogle Scholar
  14. 14.
    Lafay-Cousin L, Millar BA, Mabbott D et al (2006) Limited-field radiation for bifocal germinoma. Int J Radiat Oncol Biol Phys 65:486–492PubMedCrossRefGoogle Scholar
  15. 15.
    Mazumdar M, Bajorin DF, Higgins G, Higgins G, Motzer RJ, Bosl GJ (2001) Predicting outcome to chemotherapy in patients with germ cell tumors: the value of rate of decline of human chorionic gonadotropin and alpha-fetoprotein during therapy. J Clin Oncol 19:2534–2541PubMedGoogle Scholar
  16. 16.
    Murphy BA, Motzer RJ, Mazumdar M et al (1994) Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy. Cancer 73:2520–2526PubMedCrossRefGoogle Scholar
  17. 17.
    Perkins GL, Slater ED, Sanders GK, Prichard JG (2003) Serum tumor markers. Am Fam Physician 68:1075–8102PubMedGoogle Scholar
  18. 18.
    Robin X, Turck N, Hainard A et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinforma 12:77CrossRefGoogle Scholar
  19. 19.
    Rogers PB, Sims EC, Plowman N (1998) Blood to cerebrospinal fluid human chorionic gonadotropin-beta ratios in intracranial germ cell tumors. Neurosurg Focus 5(1):e4PubMedCrossRefGoogle Scholar
  20. 20.
    Sizaret P (1979) Equivalence between international units and mass units of alpha-foetoprotein. Report of a collaborative study. Clinica Chemica Acta 96:59–65CrossRefGoogle Scholar
  21. 21.
    Villano JL, Virk IY, Ramirez V, Propp JM, Engelhard HH, McCarthy BJ (2010) Descriptive epidemiology of central nervous system germ cell tumors: nonpineal analysis. Neuro-Oncology 12(3):257–264PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Ibrahim Qaddoumi
    • 1
    • 7
  • Miheer Sane
    • 2
    • 3
  • Shaoyu Li
    • 4
  • Mehmet Kocak
    • 4
  • Atmaram Pai-Panandiker
    • 5
  • Julie Harreld
    • 5
  • Paul Klimo
    • 6
  • Karen Wright
    • 1
  • Alberto Broniscer
    • 1
  • Amar Gajjar
    • 1
  1. 1.Department of OncologySt. Jude Children’s Research HospitalMemphisUSA
  2. 2.Department of Pediatric Oncology Education ProgramSt. Jude Children’s Research HospitalMemphisUSA
  3. 3.Cornell UniversityNew YorkUSA
  4. 4.Department of BiostatisticsSt. Jude Children’s Research HospitalMemphisUSA
  5. 5.Department of Radiological SciencesSt. Jude Children’s Research HospitalMemphisUSA
  6. 6.Department of SurgerySt. Jude Children’s Research HospitalMemphisUSA
  7. 7.St. Jude Children’s Research HospitalMemphisUSA

Personalised recommendations